C K Tham

Suggest Changes
Learn More
TPS174 Background: Dovitinib (TKI258) is an investigational multi-targeting tyrosine kinase inhibitor with potent inhibitory activity against several class III,IV,V RTKs relevant in cancer, including(More)
  • 1